Injective jumps 27% in a day, leaving NEAR and Sei behind
INJ's surge highlights potential market shifts as ETF approvals could broaden investor access, impacting supply dynamics and valuation.
Mới với thị trường — giá, lợi suất, market cap? Chúng tôi giải thích từng thuật ngữ khi bạn duyệt, bằng ngôn ngữ dễ hiểu. Cùng dữ liệu, có kèm hỗ trợ.
Bạn đã quen với thị trường. Chỉ có dữ liệu — rõ ràng, nhanh và gọn, không có giải thích thêm. Đây là chế độ xem mặc định.
Mọi số liệu trên site này đều có dạng JSON, kèm theo kỳ và nguồn.
Đọc tài liệu APICác tiêu đề đề cập đến tài sản này, từ các nhà xuất bản có tòa soạn. Các bài viết mang tính dự đoán giá được lọc bỏ trước khi đến trang này.
INJ's surge highlights potential market shifts as ETF approvals could broaden investor access, impacting supply dynamics and valuation.
Injective continued its rebound on Friday, trading around $9.25 as improving momentum and declining exchange balances supported a constructive outlook.
Long-term investors will want to see prices climb past $13.575 comfortably before looking for signs of a long-term trend shift.
Injective has rallied more than 8% on October 16, reaching $9.35 as increased trading activity and renewed interest in the network's institutional developments have…
Injective records significant gains as Gulf Labs joined its institutional validators with its trading volume and open interest spiking sharply recently.
Injective's integration of tokenized assets could revolutionize financial markets by enhancing accessibility and regulatory compliance on-chain.
Injective's fixed gas fees could enhance DeFi trading efficiency, offering cost predictability and potentially attracting more high-frequency traders.
Injective's partnership with Gulf Labs could significantly enhance its presence in Asia, potentially transforming Thai financial sectors.
Injective's quantum-resistant infrastructure development could enhance blockchain security, influencing future cryptographic standards.
Tokens left exchanges as derivatives exposure grew. Are holders settling in while traders chase the rally?
The Injective Trench Treasury's launch signifies a strategic shift towards rewarding sustainable community-driven projects, fostering long-term ecosystem growth.
Injective ecosystem saw two major developments; Injective Foundation launched the Trench Treasury while Canary Capital filed with the SEC for Staked INJ ETF.
There are currently three INJ ETF applications: the 21Shares Injective ETF, the Canary Staked INJ ETF, and the REX-Osprey INJ Staking ETF.
The advancing ETF applications could enhance INJ's market presence, potentially influencing broader crypto investment trends and regulatory landscapes.
RUNNER's innovative treasury strategy could significantly impact token supply dynamics, linking its value closely to INJ's market performance.
Injective's CypherOS demo highlights the growing demand for privacy in blockchain, potentially reshaping institutional trading dynamics.
Injective's Stockdrop could revolutionize equity access, offering decentralized, 24/7 trading and potentially reshaping traditional markets.
Canary Capital amended its staked Injective ETF filing with the U.S. Securities and Exchange Commission (SEC).
Injective has confirmed that Injective CypherOS, a native on-chain privacy layer, is coming to the network.
The Meridian upgrade positions Injective as a compliance-native blockchain, potentially boosting institutional adoption and INJ token demand.
Injective's collaboration with Microsoft could accelerate AI-blockchain integration, potentially transforming digital commerce and financial systems.
The SEC's review of the 21Shares Injective ETF could accelerate mainstream adoption of altcoins, impacting market dynamics and investor strategies.
The crypto market has seen over $630 million liquidated in the past 24 hours after the Clarity Act vote sentiment shift.
Injective's growth in RWA perpetual markets highlights a shift towards 24/7 synthetic trading, challenging traditional market structures.
Injective's upgrade enhances regulatory compliance and interoperability, potentially positioning it as a leader in tokenized securities.
Injective's blockchain dominance in tokenized real estate could reshape asset management, but reliance on Pineapple poses concentration risks.
Injective soared 13%, flipped $6 resistance, and climbed to a three-month high of $6.7.
Injective's privacy initiative could redefine blockchain's role in institutional finance, balancing confidentiality with regulatory compliance.
The mortgage lender plans to bring more than $10 billion in historical loans onchain, turning thousands of mortgage files into blockchain-based records.
Pineapple Financial's blockchain migration could revolutionize mortgage data transparency and risk assessment, setting a precedent for the industry.